Clinical Research Directory

Feasibility of Ambulatory Talc. Pleurodesis

Sponsor: David Rollins

Summary

Patients with malignant pleural disease often experience a significant symptom burden and a short life expectancy. The cornerstone of their treatment is relieving breathlessness by draining fluid from around the lungs and attempting to prevent further fluid build up. Inpatient chest drainage and talc pleurodesis remains the most successful method of stopping the fluid build up but this often requires an average hospital stay of four days. This can be an inappropriate length of time for this patient group. Our study would investigate whether this treatment could be provided on an outpatient, ambulatory basis and facilitate a greater quality of life. The investigators would assess deliverability of the trial protocol and collect patient feedback to see if our patients consider it an acceptable and worthwhile intervention.

Official title: Can Talc Pleurodesis for Malignant Pleural Effusion be Performed on an Ambulatory Basis

Key Details

Conditions

Interventions

Locations (1)